Pregnancy Clinical Trial
Official title:
The Effect of Light on the Fetal Biophysical Profile
Since the 1960's, perinatal mortality in the United States has been declining at a steady
rate. This decline has thought to be the result of improved surveillance of normal and
abnormal fetal behavior and using that information to determine those babies at risk for
stillbirth.
There are many tools available for surveillance. One of these tools, the bio-physical profile
(BPP), incorporates a non-stress test (NST) with ultrasound assessment of fetal behavior .
This test has been used for about the last 30 years with good safety and efficacy. The
ultrasound evaluation includes monitoring fetal breathing, fetal gross and fine movement and
amniotic fluid evaluation. NST and BPP have been found to have similar ability to predict
fetal well-being, with similar safety and ease of performance. Several studies have observed
the effect of sound as well as light on the NST and have found that it can shorten testing
time without altering its ability to be interpreted properly or affecting fetal safety.
However, similar studies have not been done with the BPP. Light stimulation has been proven
to be safe for both the mother and the fetus with no harm having been demonstrated when used
with NST.
Since the 1960's, perinatal mortality in the United States has been declining at a steady
rate. This decline has thought to be the result of improved surveillance of normal and
abnormal fetal behavior and using that information to determine those babies at risk for
stillbirth.
There are many tools available for surveillance. One of these tools, the bio-physical profile
(BPP), incorporates a non-stress test (NST) with ultrasound assessment of fetal behavior .
This test has been used for about the last 30 years with good safety and efficacy. The
ultrasound evaluation includes monitoring fetal breathing, fetal gross and fine movement and
amniotic fluid evaluation. NST and BPP have been found to have similar ability to predict
fetal well-being, with similar safety and ease of performance. Several studies have observed
the effect of sound as well as light on the NST and have found that it can shorten testing
time without altering its ability to be interpreted properly or affecting fetal safety.
However, similar studies have not been done with the BPP. Light stimulation has been proven
to be safe for both the mother and the fetus with no harm having been demonstrated when used
with NST.
Since the 1960's, perinatal mortality in the United States has been declining at a steady
rate. This decline has thought to be the result of improved surveillance as well as neonatal
and infant care. However, there is still a large percentage of mortality that is related to
antenatal fetal and maternal complications. There has been much research in this area, to
help predict which fetuses are more likely to have a poor outcome, and may benefit from
intervention, such as early delivery. Several tests have been developed to help monitor fetal
behavior and differentiate between fetal well-being and identify those at risk for adverse
outcomes. Some of these tests include the contraction-stress test (CST) and the bio-physical
profile (BPP), which incorporates the NST with ultrasound assessment of fetal behavior. These
tests accurately reflect the acid-base status of the fetus as well as the level of fetal
oxygenation.
The biophysical profile was originally developed as a method of assessing fetal health and
help determine whether or not a complication of pregnancy was severe enough to warrant
delivery. The time length needed to complete a biophysical profile is variable. The test is
considered completed if the fetus meets all criteria. The test consists of four ultrasound
components, and electronic fetal monitoring component: fetal heart rate reactivity by
non-stress test, fetal breathing movements, fetal gross body movements, fetal tone/posture
and amniotic fluid evaluation.
These components are scored as a "2" for present and "0" if not present. This makes for a
maximum score of 10. Scores of 8 or greater are generally considered reassuring. A score of 6
is considered equivocal and requires further evaluation and follow-up. A score of 4 is
concerning and delivery plan should be initiated soon. A score of 2 or 0 should means the
fetus should be delivered immediately.
Fetal heart rate reactivity is assessed with a fetal non-stress test using a external
electronic fetal monitor. The mother has an external tocodynomometer and a small doppler
device placed over the area of the fetal chest placed on her abdomen. The test is considered
"reactive" when there are two defined accelerations of the fetal heart rate above the
baseline rate during the 20 to 30 minute testing period. The size of the acceleration
required depends on the gestational age of the fetus. Testing time can be extended up to 60
minutes to obtain reactivity if the fetus happens to be in a passive sleep state during the
test.
Fetal breathing movements have been seen by ultrasound beginning in the early second
trimester. The consist of intermittent "practice" breathing by the fetus where the diaphragm
can be seen moving similarly to adults. These movements last greater than 30 seconds but are
not continuous. This is the first finding to be lost when fetal hypoxemia is present.
Body or limb movements are generally decreased in fetuses that are hypoxic. This corresponds
to decreased activity level for metabolic conservation in those fetuses that are compromised.
Three or more discrete movements are required for this to be considered present.
Fetal tone and posture are demonstration of active extension with rapid return to flexion of
fetal limbs and brisk repositioning or trunk rotation. Opening and closing of hand or mouth,
kicking, and so on. One example must be observed for this to be considered present during the
exam.
Amniotic fluid evaluation is considered present when at least one pocket of fluid is seen on
ultrasound measuring greater than 2 centimeters without umbilical cord present.
Response of fetuses to light stimulation has been known since 1975 when Polishuk reporting
fetal movement after 26 weeks gestation in fetuses stimulated by light. In 1980, Peleg and
Goldman performed amnioscopy and noted an acceleration in the fetal heart rate in 80% of
patients after being exposed to the light of the amnioscope. Caridi et al. noted that fetuses
stimulated with halogen light took less time to become reactive on a non-stress test than
fetuses that were not stimulated. No study has noted an adverse maternal or fetal event from
use of light stimulation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02523755 -
Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia
|
Phase 4 |